Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.

Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.

Item
http://www.wikidata.org/entity/Q34659424
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug developmentThe burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg.New pharmacological approaches for obesity management.Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Obesity and type 2 diabetes: which patients are at risk?Drug treatment of obesity in cardiovascular disease.Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk.Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?[Recent progress and novel perspectives on obesity pharmacotherapy].Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.
P2860

Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.

Item
http://www.wikidata.org/entity/Q34659424
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@ast
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@en
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@nl
type
label
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@ast
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@en
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@nl
prefLabel
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@ast
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@en
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Lorcaserin and adiposopathy: 5 ...... ck fat' and metabolic disease.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921